Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$10.13 - $13.98 $19 Million - $26.2 Million
-1,875,880 Reduced 92.43%
153,700 $1.76 Million
Q3 2021

Nov 15, 2021

BUY
$8.19 - $11.31 $6.1 Million - $8.42 Million
744,680 Added 57.96%
2,029,580 $21.7 Million
Q3 2020

Nov 16, 2020

BUY
$7.15 - $11.5 $9.19 Million - $14.8 Million
1,284,900 New
1,284,900 $11.3 Million

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.